TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31

TRINITY BIOTECH PLC

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026

$8.19+0.16 (+1.99%)

Close on Oct 19, 2026

Price history

Daily open, high, low, close and volume

Date	Open	High	Low	Close	Change	Volume
Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected.

From SEC filings

Date	Ratio	Effect on per-share figures
Jul 24, 2026	1-for-30 reverse	Earlier per-share figures multiplied by 30
Feb 23, 2024	1-for-5 reverse	Earlier per-share figures multiplied by 5
Jun 2, 2005	1-for-4 reverse	Earlier per-share figures multiplied by 4

Parsed from the XBRL in Trinity Biotech's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-30 reverse split on Jul 24, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is TRIB.

Revenue growth-28.9% · median 10.4%

Gross margin38.6% · median 40.3%

Operating margin-36.1% · median -33.5%

Net margin-85.4% · median -38.8%

Advertisement
300 × 250